Dr. Jen Gunter

And then when the study results came out that there were a statistically significant increased incidence of breast cancer,

what do you think would have then been the confidence in government-run clinical trials?

What do you think would have happened with lawsuits and the government?

And so it's very easy for people to play armchair quarterback, but in fact, we know that there were tons of lawsuits about breast cancer, even though, as Marty Makary likes to point out, the risk wasn't statistically significant.

It was a trend in the first publication.

In the later publications, it was statistically significant.

It's very easy to cherry pick.

That there were all kinds of lawsuits about it.

So, of course, I mean, I can't say, of course, because I don't have a crystal ball.

But you would think that, you know, if the fears had become true, what would have happened with lawsuits?

Right.

So the context all matters.

And so.

And people love to cherry pick from the WHI and talk about how, oh, estrogen alone reduces the risk of breast cancer.

Well, no, Premarin does.

Premarin is a different molecule, pregnant mare's urine.

And it has, I mean, depending on the marketing you believe, it's got 16 different molecules, 26, I don't know.

But it's got all these different molecules in it and some are selective estrogen receptor modulators.

which we know that there are selective estrogen receptor modulators that can lower the risk of breast cancer.

So Premarin's a really unique molecule.